Billionaire to back cancer, Covid vaccines in SA

ImmunityBio company is conducting trials of its Covid-19 vaccine in SA and has held talks with Cape Town’s Biovac Institute to potentially set up vaccine production facilities.
Image: David Paul

South African-born biotech billionaire Patrick Soon-Shiong will announce a plan to transfer technology for the manufacture of Covid-19 and cancer vaccines to the African country.

The California-based entrepreneur will make the announcement at 5 p.m. local time Thursday with President Cyril Ramaphosa, the South African presidency said in a statement.

Soon-Shiong’s NantWorks has signed a collaboration agreement with the South African government’s Council for Scientific and Industrial Research, the South African Medical Research Council and the Centre for Epidemic Response and Innovation. Three local universities are also party to the agreement.

Soon-Shiong, who has a net worth of $11 billion according to the Bloomberg Billionaires Index, was born in the South African coastal town of Gqeberha. He made his fortune after inventing cancer drug Abraxane in the US and has sold two firms for a combined $7.4 billion. His assets include the Los Angeles Times newspaper and a share of the Los Angeles Lakers basketball team.

His ImmunityBio Inc. company is conducting trials of its Covid-19 vaccine in South Africa and has held talks with Cape Town’s Biovac Institute to potentially set up vaccine production facilities in the country.

© 2021 Bloomberg

COMMENTS   1

You must be signed in to comment.

SIGN IN SIGN UP

End of comments.

LATEST CURRENCIES  

USD / ZAR
GBP / ZAR
EUR / ZAR
BTC / USD

Podcasts

INSIDER SUBSCRIPTIONS APP VIDEOS RADIO / LISTEN LIVE SHOP OFFERS WEBINARS NEWSLETTERS TRENDING PORTFOLIO TOOL CPD HUB

Follow us:

Search Articles:
Click a Company: